Literature DB >> 11576762

Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium.

M B Knable1, E F Torrey, M J Webster, J J Bartko.   

Abstract

Prefrontal cortical tissue from the Stanley Foundation Neuropathology Consortium, which contains samples from patients with schizophrenia, bipolar disorder, non-psychotic depression, and normal controls (n = 15 per group), was studied in a blinded fashion in 14 different laboratories between 1997 and 2000. The results of 69 separate data sets were analyzed with univariate and multivariate techniques. A total of 17 abnormal markers were identified that pertained to a variety of neural systems and processes, including neuronal plasticity, neurotransmission, signal transduction, inhibitory interneuron function, and glial cells. Schizophrenia was associated with the largest number of abnormalities, many of which were also present in bipolar disorder. Major depression was associated with relatively few abnormalities. The majority of abnormal findings represented a decline in function and could not be easily explained by exposure to psychotropic or illicit drugs. It is argued that the abnormal findings are not simply due to stochastic processes but represent viable markers for independent replication and further study as candidate genes or targets for new treatments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576762     DOI: 10.1016/s0361-9230(01)00521-4

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  30 in total

1.  Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors.

Authors:  Claudia Erbel-Sieler; Carol Dudley; Yudong Zhou; Xinle Wu; Sandi Jo Estill; Tina Han; Ramon Diaz-Arrastia; Eric W Brunskill; S Steven Potter; Steven L McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-03       Impact factor: 11.205

Review 2.  Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.

Authors:  Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

3.  Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness.

Authors:  Duncan Sinclair; Shan Yuan Tsai; Heng Giap Woon; Cynthia Shannon Weickert
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

4.  Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders.

Authors:  S Kim; Y Hwang; M J Webster; D Lee
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

5.  Transcriptomic Evidence for Alterations in Astrocytes and Parvalbumin Interneurons in Subjects With Bipolar Disorder and Schizophrenia.

Authors:  Lilah Toker; Burak Ogan Mancarci; Shreejoy Tripathy; Paul Pavlidis
Journal:  Biol Psychiatry       Date:  2018-07-21       Impact factor: 13.382

6.  Adjusting for matching and covariates in linear discriminant analysis.

Authors:  Josephine K Asafu-Adjei; Allan R Sampson; Robert A Sweet; David A Lewis
Journal:  Biostatistics       Date:  2013-05-02       Impact factor: 5.899

Review 7.  Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.

Authors:  Gloria Laryea; Lisa Muglia; Melinda Arnett; Louis J Muglia
Journal:  Front Neuroendocrinol       Date:  2014-09-27       Impact factor: 8.606

8.  Glucocorticoid receptor alpha translational isoforms as mediators of early adversities and negative emotional states.

Authors:  Miroslav Adzic; Emilija Glavonic; Milica J Nesic; Minja Milosavljevic; Marina Mihaljevic; Zorica Petrovic; Zorana Pavlovic; Zeljka Brkic; Ester Francija; Ivan Soldatovic; Milos Mitic; Jelena Radulovic; Nadja P Maric
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-12-21       Impact factor: 5.067

9.  Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.

Authors:  Amy E Steffek; Robert E McCullumsmith; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2008-06-17       Impact factor: 4.939

10.  The schizophrenias, the neuroses and the covered wagon; a critical review.

Authors:  C Raymond Lake; Nathaniel Hurwitz
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.